Phase i dose-escalation study of SGN-75 in patients with CD70-positive relapsed/refractory non-Hodgkin lymphoma or metastatic renal cell carcinoma

Nizar M. Tannir, Andres Forero-Torres, Radhakrishnan Ramchandren, Sumanta K. Pal, Stephen M. Ansell, Jeffrey R. Infante, Sven De Vos, Paul A. Hamlin, Stella K. Kim, Nancy C. Whiting, Elaina M. Gartner, Baiteng Zhao, John A. Thompson

Research output: Contribution to journal › Article › peer-review

63 Scopus citations

Fingerprint

Dive into the research topics of 'Phase i dose-escalation study of SGN-75 in patients with CD70-positive relapsed/refractory non-Hodgkin lymphoma or metastatic renal cell carcinoma'. Together they form a unique fingerprint.

Medicine & Life Sciences